ArticleRespiratory medicine case reports2025

Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer.

Mostafa Aglan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.